OTCMKTS:SAUHY - Straumann Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 7
  • Breakdown:
  • 3 Sell Ratings
  • 3 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$58.97
▼ -0.14 (-0.24%)
1 month | 3 months | 12 months
Get New Straumann Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SAUHY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SAUHY

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Straumann in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $58.97.
Hold
The current consensus among 7 investment analysts is to hold stock in Straumann. This rating has held steady since November 2020, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
7/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 1 sell ratings
10/27/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 2 sell ratings
4/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings
7/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings
10/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 3 sell ratings
12/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 3 sell ratings
1/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 3 sell ratings

DateBrokerageActionRatingPrice TargetDetails
1/13/2021Credit Suisse GroupReiterated RatingOutperform
i
1/11/2021Stifel NicolausDowngradeBuy ➝ Hold
i
12/9/2020Morgan StanleyReiterated RatingUnderweight
i
11/23/2020Credit Suisse GroupReiterated RatingOutperform
i
10/29/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
10/14/2020Berenberg BankReiterated RatingHold
i
10/6/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
i
10/5/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
8/24/2020Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
i
8/17/2020Berenberg BankReiterated RatingHold
i
8/14/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
8/7/2020Berenberg BankReiterated RatingHold
i
7/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
6/30/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
i
5/29/2020Morgan StanleyDowngradeOverweight ➝ Underweight
i
5/21/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
5/15/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
i
4/27/2020Berenberg BankReiterated RatingHold
i
4/17/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell
i
4/9/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
i
4/1/2020JPMorgan Chase & Co.Reiterated RatingNeutral
i
1/31/2020Berenberg BankDowngradeHold ➝ Sell
i
1/30/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy
i
1/11/2019Jefferies Financial GroupUpgradeHold ➝ Buy
i
12/10/2018Morgan StanleyUpgradeEqual Weight ➝ Overweight
i
10/3/2017CitigroupUpgradeSell ➝ Neutral
i
8/22/2017Kepler Capital MarketsUpgradeReduce ➝ Hold
i
(Data available from 1/19/2016 forward)
Straumann logo
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implant systems, biomaterials, CADCAM prosthetics, digital equipment, software, clear aligner systems, and various materials for dental applications. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides biomaterials, such as bone augmentation materials, membranes, fleeces, and sponges; ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
Read More

Today's Range

Now: $58.97
$57.15
$58.97

50 Day Range

MA: $58.43
$56.52
$60.60

52 Week Range

Now: $58.97
$27.34
$63.07

Volume

7,600 shs

Average Volume

7,220 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Straumann?

The following Wall Street analysts have issued research reports on Straumann in the last twelve months: Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Stifel Nicolaus, and The Goldman Sachs Group, Inc..

What is the current price target for Straumann?

0 Wall Street analysts have set twelve-month price targets for Straumann in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Straumann in the next year.

What is the current consensus analyst rating for Straumann?

Straumann currently has 3 sell ratings, 3 hold ratings and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SAUHY, but not buy more shares or sell existing shares.

What other companies compete with Straumann?

How do I contact Straumann's investor relations team?

The company's listed phone number is 41 61 965 11 11. The official website for Straumann is www.straumann.com.